home / stock / mreo / mreo news

MREO News and Press, Mereo BioPharma Group From 10/20/20

Stock Information
Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com
Menu
MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...
MREO - Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs

LONDON and REDWOOD CITY, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) (“Mereo” or “the Company”), a clinical stage biopharmaceutical company focused on oncology and rare diseases, today announced the appointment of ...
MREO - Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)

On track to initiate Phase 1b/2 basket study of etigilimab in combination with an anti-PD-1 in a series of tumor types in Q4 2020 Plans to host virtual R&D day to review etigilimab development program and rare disease product pipeline in November 2020 LONDON and REDWOOD CITY, ...

MREO - Mereo BioPharma's (MREO) CEO Denise Scots-Knight on 2020 Interim Financial Results Conference Call Transcript

Mereo BioPharma Group plc (MREO) 2020 Interim Financial Results Conference Call September 29, 2020 08:00 A.M. ET Company Participants Steve Klass - VP, Burns McClellan Denise Scots-Knight – CEO Michael Wyzga – Interim CFO John Lewicki - Chief Scientific Officer Conference Call P...

MREO - Mereo BioPharma Announces Interim Financial Results for the Six Months Ended June 30, 2020 and Provides Corporate Update

On track to initiate Phase 1b/2 etigilimab (Anti-TIGIT) combination study in Q4 2020 Enrolment resumed in Phase 2 study of alvelestat in Alpha-1 Antitrypsin Deficiency and initiated placebo-controlled Phase 1b/2 clinical trial in COVID-19 respiratory disease Partnering discussions...
MREO - BB, CODX among premarket gainers

Sunworks (SUNW) +355%.Polar Power (POLA) +88%.The E.W. Scripps Company (SSP) +68% on ION Media acquisition.SPI Energy (SPI) +51%.LogicBio Therapeutics (LOGC) +45%.Owens & Minor (OMI) +28% after raising full-year guidance.Electrameccanica Vehicles (SOLO) +16% ...

MREO - Mereo BioPharma +8% on rare pediatric disease designation to Setrusumab

U.S. Food and Drug Administration grants Mereo BioPharma (MREO) +8% rare pediatric disease designation to setrusumab for the treatment of osteogenesis imperfecta.Setrusumab is a fully humanized monoclonal antibody that inhibits sclerostin, a protein which inhibits the activity of bo...

MREO - Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta

LONDON and REDWOOD CITY, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announces that the U.S. Food ...
MREO - Mereo BioPharma to Announce Interim Financial Results for the Six Months Ended June 30, 2020 and Host Conference Call on September 29, 2020

LONDON and REDWOOD CITY, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announces that it will releas...

MREO - Mereo Bio launches mid-stage alvelestat trial in COVID-19

Mereo BioPharma (NASDAQ: MREO )   jumps 10%  premarket after initiating a Phase 1b/2 clinical trial to evaluate the safety and efficacy of alvelestat in hospitalized, adult patients with moderate to severe COVID-19 respiratory disease. More news on: Mereo BioPharma Group plc, ...

MREO - RIG, GPS among premarket gainers

Urban One (NASDAQ: UONE ) +85% . More news on: Urban One, Inc., Ovid Therapeutics Inc., RealNetworks, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10